Clinical Trial Update: COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS [Phase 4]

View source ↗

Summary

Phase 4 trial comparing pharmacodynamics and pharmacokinetics of ticagrelor versus clopidogrel in patients with chronic kidney disease and non-ST-segment elevat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Non-st-segment Elevation Acute Coronary Syndrome

Drugs mentioned

• Clopidogrel (Plavix) (clopidogrel)
• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Non ST Segment Elevation Acute Coronary Syndrome, Chronic Kidney Disease | Phase 4 | Status: UNKNOWN